Phase 1 study of the Aurora kinase A inhibitor alisertib (MLN8237) combined with the histone deacetylase inhibitor vorinostat in lymphoid malignancies.
Leuk Lymphoma
; 61(2): 309-317, 2020 02.
Article
in En
| MEDLINE
| ID: mdl-31617432
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Histone Deacetylase Inhibitors
/
Aurora Kinase A
/
Vorinostat
/
Lymphoproliferative Disorders
Limits:
Humans
Language:
En
Journal:
Leuk Lymphoma
Journal subject:
HEMATOLOGIA
/
NEOPLASIAS
Year:
2020
Document type:
Article
Affiliation country:
United States
Country of publication:
United States